Firvanq will replace CutisPharma's FIRST-Vancomycin Unit-of-Use Compounding Kit. CutisPharma announced the availability of Firvanq (vancomycin HCl) for oral solution to treat Clostridium ...
WILMINGTON, Mass., April 2, 2018 /PRNewswire/ -- CutisPharma announced today the commercial launch of FIRVANQ™ (vancomycin hydrochloride) for oral solution, for the treatment of Clostridium difficile ...
Vancomycin is indicated to treat enterocolitis caused by Staphylococcus aureus and antibiotic-associated pseudomembranous colitis caused by C. difficile. ANI Pharmaceuticals announced that the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results